News releases from Autolus Therapeutics plc
Autolus Therapeutics provides business outlook for 2021 & 2022
January 06, 2021
Tickers
AUTL
Tickers
AUTL
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual Meeting
December 07, 2020
Tickers
AUTL
Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting
December 05, 2020
Tickers
AUTL
Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine
November 30, 2020
Tickers
AUTL
Tickers
AUTL
Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress
November 05, 2020
Tickers
AUTL
Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5
October 30, 2020
Tickers
AUTL
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020
September 18, 2020
Tickers
AUTL
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September
September 08, 2020
Tickers
AUTL
Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress
August 06, 2020
Tickers
AUTL
Autolus announces changes to its Board and Management Team
August 04, 2020
Tickers
AUTL
Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6
July 30, 2020
Tickers
AUTL
Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting
June 22, 2020
Tickers
AUTL
Tickers
AUTL
Tickers
AUTL
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
May 29, 2020
Tickers
AUTL
Tickers
AUTL
Tickers
AUTL
Tickers
AUTL
Autolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual Meeting
May 15, 2020
Tickers
AUTL
Autolus Therapeutics to Present New Data on AUTO3 during the ASCO20 Virtual Scientific Program
May 14, 2020
Tickers
AUTL
Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress
May 07, 2020
Tickers
AUTL
Autolus Therapeutics to Report First Quarter 2020 Financial Results and Host Conference Call on May 7
May 01, 2020
Tickers
AUTL
Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic Leukemia
April 16, 2020
Tickers
AUTL
Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress
March 03, 2020
Tickers
AUTL
Tickers
AUTL
Autolus Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 3
February 24, 2020
Tickers
AUTL
Autolus Therapeutics Presents Encouraging Additional Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers
January 30, 2020
Tickers
AUTL
Autolus Announces Closing of Public Offering
January 27, 2020
Tickers
AUTL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.